1. (a) Scope and applicability. Monitoring for symptoms of tardive dyskinesia (TD) applies to all service recipients who receive medication associated with a risk of TD. Providers of residential services funded by Oklahoma Human Services DDS or Oklahoma Health Care Authority have primary responsibility for implementation of OAC 340:100-5-29. Providers of other types of supports inform service recipients and encourage the implementation of OAC 340:100-5-29.
2. (b) Monitoring requirements.
3. (1) Developmental Disabilities Services (DDS) provides health related services training for staff to recognize symptoms of TD, risk factors for the development of TD, and medication associated with these potential adverse effects.
4. (2) Service provider staff monitors for symptoms of TD in service recipients at risk and reports observations to the prescribing healthcare provider.
5. (3) Service provider staff requests copies of TD assessments completed by the prescribing healthcare provider or designee and file in the service recipient's record.

Added at 10 Ok Reg 2505, eff 5-24-93 (emergency)

Added at 11 Ok Reg 2303, eff 5-26-94

Amended at 23 Ok Reg 1026, eff 5-11-06

Amended at 25 Ok Reg 986, eff 5-15-08

Amended at 40 Ok Reg 1005, eff 9-15-23

Amended at 42 Ok Reg, Number 20, effective 9-15-25